IMU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmunoGen Inc

Watchlist Manager

Watchlist

Price: 0.105 EUR -99.63% Market Closed

Market Cap: €8.1B

I	ImmunoGen Inc F:IMU	US
C	Christian Dior SE XBER:DIO	FR
I	International Consolidated Airlines Group SA XMUN:INR	UK
	Meta Platforms Inc BMV:META	US
	Roper Technologies Inc SIX:ROP	US

Profitability Summary

ImmunoGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

99%

Gross Margin is Increasing

91% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-28%

Operating Margin is Increasing

-97% > -28%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-26%

Net Margin is Increasing

-96% > -26%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-69%

Free Cash Flow Margin is Increasing

-140% > -69%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-74%

ROIC is Increasing

-240% > -74%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

99%

Gross Margin is Increasing

91% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-28%

Operating Margin is Increasing

-97% > -28%